Pressotherapy Systems Market Outlook:
Pressotherapy Systems Market size was USD 256.4 million in 2025 and is expected to reach USD 408.1 million by the end of 2035, increasing at a CAGR of 5.3% during the forecast period, i.e., 2026-2035. In 2026, the industry size of pressotherapy systems is estimated at USD 269.9 million.
The market has achieved international traction, owing to factors including a rise in circulatory and lymphatic disorders, increased awareness, and technological innovation in device design. According to an article published by NLM in April 2022, pressotherapy systems constitute the capability to significantly reduce muscle soreness by 7% from 24 to 96 hours. Besides, during post-exercise (Po-E), the utilization of these systems assist in reducing the condition by 43%. Meanwhile, excessive exercise can lead to delayed onset muscle soreness (DOMS), leading to an increase in serum creatine kinase activity, which can be diminished by pressotherapy intervention by 63%, thus suitable for the market’s upliftment.
Moreover, the cause of cardiovascular disease (CVD) is also another driver for boosting the market demand. According to the 2025 WHO report, this particular disease is one of the leading causes of death, including an estimated 17.9 million lives globally. In addition, over 4 out of 5 CVD deaths take place, owing to heart strokes and attacks, and 1/3 of these deaths happen prematurely among people aged 70 years. Besides, the November 2024 WHO report indicated that more than 657 million people across 39 countries globally suffer from lymphatic filariasis, and over 9.7 billion cumulative treatments have been provided to reduce the transmission, which is yet another reason for augmenting the market’s demand.
